Adam A. Capoferri,Ann Wiegand,Feiyu Hong,Jana L. Jacobs,Jonathan Spindler,Andrew Musick,Michael J. Bale,Wei Shao,Michele D. Sobolewski,Anthony R. Cillo,Brian T. Luke,Christine M. Fennessey,Robert J. Gorelick,Rebecca Hoh,Elias K. Halvas,Steven G. Deeks,John M. Coffin,John W. Mellors,Mary F. Kearney
标识
DOI:10.1101/2024.07.01.601579
摘要
Abstract In the absence of antiretroviral therapy (ART), a subset of individuals, termed HIV controllers, have levels of plasma viremia that are orders of magnitude lower than non-controllers who are at higher risk for HIV disease progression. In addition to having fewer infected cells resulting in fewer cells with HIV RNA, it is possible that lower levels of plasma viremia in controllers is due to a lower fraction of the infected cells having HIV-1 unspliced RNA (HIV usRNA) compared with non-controllers. To directly test this possibility, we used sensitive and quantitative single cell sequencing methods to compare the fraction of infected cells that contain one or more copies of HIV usRNA in peripheral blood mononuclear cells (PBMC) obtained from controllers and non-controllers. The fraction of infected cells containing HIV usRNA did not differ between the two groups. Rather, the levels of viremia were strongly associated with the total number of infected cells that had HIV usRNA, as reported by others, with controllers having 34-fold fewer infected cells per million PBMC. These results reveal for the first time that viremic control is not associated with a lower fraction of proviruses expressing HIV usRNA, unlike what is reported for elite controllers, but is only related to having fewer infected cells overall, maybe reflecting greater immune clearance of infected cells. Our findings show that proviral silencing is not a key mechanism for viremic control and will help to refine strategies towards achieving HIV remission without ART.